Delcath Systems (DCTH) Liabilities and Shareholders Equity (2010 - 2026)
Delcath Systems (DCTH) recorded quarterly Liabilities and Shareholders Equity of $124.8 million in Q1 2026, up 0.98% quarter-over-quarter from $123.6 million in Q4 2025, and up 42.97% on a YoY basis from $87.3 million in Q1 2025.
Delcath Systems (DCTH) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Delcath Systems' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $124.8 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 42.97% year-over-year to $124.8 million; the TTM figure through Mar 2026 stood at $489.6 million (up 113.35% YoY), while the FY2025 annual figure was $123.6 million, up 61.42% from the prior year.
- Liabilities and Shareholders Equity was $124.8 million for Q1 2026 at Delcath Systems, up from $123.6 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $124.8 million in Q1 2026 to a low of $17.9 million in Q4 2022.
- Historically, Liabilities and Shareholders Equity has averaged $57.6 million across 5 years, with a median of $36.1 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity tumbled 46.08% in 2022, then surged 292.33% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $17.9 million in 2022, then surged by 116.17% to $38.6 million in 2023, then soared by 98.35% to $76.6 million in 2024, then surged by 61.42% to $123.6 million in 2025, then gained by 0.98% to $124.8 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $124.8 million (Q1 2026), $123.6 million (Q4 2025), and $124.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Delcath Systems | 420.91 Mn | 331.59 Mn | 21.26 Mn | 124.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.84 Mn |
| Dec 31, 2025 | 123.63 Mn |
| Sep 30, 2025 | 124.30 Mn |
| Jun 30, 2025 | 116.88 Mn |
| Mar 31, 2025 | 87.32 Mn |
| Dec 31, 2024 | 76.59 Mn |
| Sep 30, 2024 | 31.68 Mn |
| Jun 30, 2024 | 33.91 Mn |
| Mar 31, 2024 | 36.10 Mn |
| Dec 31, 2023 | 38.61 Mn |
| Sep 30, 2023 | 47.58 Mn |
| Jun 30, 2023 | 21.05 Mn |
| Mar 31, 2023 | 30.60 Mn |
| Dec 31, 2022 | 17.86 Mn |
| Sep 30, 2022 | 20.23 Mn |
| Jun 30, 2022 | 21.07 Mn |
| Mar 31, 2022 | 27.32 Mn |
| Dec 31, 2021 | 33.12 Mn |
| Sep 30, 2021 | 34.43 Mn |
| Jun 30, 2021 | 24.92 Mn |